Active, Not Recruiting
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
NCT05966480
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- Investigator Site #1046 Anniston, Alabama, United States
- Investigator Site #1104 La Jolla, California, United States
- Investigator Site #1050 Los Alamitos, California, United States
- Investigator Site #1168 Mission Hills, California, United States